13788-14-2

Upstream product

• 1129-37-9 4-nitrobenzaldehyde oxime 
• 555-16-8 4-nitrobenzaldehdye 
• 1011-84-3 4-nitrobenzohydroximoyl chloride 
• 123-54-6 acetylacetone 

Downstream Products

• 13788-15-3 [5-methyl-3-(4-nitro-phenyl)-isoxazol-4-yl]-oxo-acetaldehyde hydrate 
• 15562-69-3 2-[5-methyl-3-(4-nitro-phenyl)-isoxazol-4-yl]-quinoxaline 
• 13917-30-1 4-(1⁽³⁾H-imidazol-4-yl)-5-methyl-3-(4-nitro-phenyl)-isoxazole 
• 13788-19-7 isonicotinic acid {2-[5-methyl-3-(4-nitro-phenyl)-isoxazol-4-yl]-2-oxo-ethylidene}-hydrazide 
• 13788-18-6 4-{2-[5-methyl-3-(4-nitro-phenyl)-isoxazol-4-yl]-2-oxo-ethylideneamino}-benzoic acid 
• 15581-17-6 3-[5-methyl-3-(4-nitro-phenyl)-isoxazol-4-yl]-pyrido[2,3-b]pyrazine 

Relevant academic research and scientific papers

Design, Synthesis, Molecular Docking Studies, and Biological Evaluation of Pyrazoline Incorporated Isoxazole Derivatives

Abstract: A novel series of pyrazoline incorporated isoxazole derivatives were designed and synthesized. The synthesized compounds were characterized by 1H NMR, IR and ESI-MS spectra. In addition, all the synthesized compounds were docked with

Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents

A series of novel isoxazolyl chalcones were synthesized and evaluated for their activities in vitro against four types of human non-small cell lung cancer cells, including H1792, H157, A549 and Calu-1 cells. The preliminary biological screening showed tha